Scott serves as Director of the Dana-Farber/Harvard Cancer Center Program in Cancer Outcomes Research Training. Scott is also Senior Scientist at the Partners Institute for Health Policy, and Director of Clinical Research in the Department of Radiology at the Massachusetts General Hospital. He is Past President of the Association of University Radiologists, the Radiology Research Alliance, and the New England Roentgen Ray Society. He is currently Chair of the American College of Radiology Commission on Research and Technology Assessment, and past Chair of the RSNA Research Development Committee, as well as past member of the Medicare Coverage Advisory Committee.

Dr. Gazelle received his BA from Dartmouth College, and his MD from Case Western Reserve University School of Medicine. He completed a Radiology residency at University Hospitals of Cleveland, where he also served as Chief Resident. Following residency, he completed a fellowship in Abdominal Imaging and Interventional Radiology at the Massachusetts General Hospital, and then joined the faculty at the MGH in the Division of Abdominal Imaging and Interventional Radiology. In 1996, he received an MPH from the Harvard School of Public Health, where he majored in Health Care Management. In 1999, he received a PhD in Health Policy from Harvard University, where he concentrated in Decision Science.

His research focuses on evaluating the benefits, costs, and appropriate use of new medical technologies. Scott has authored more than 150 scientific articles, published 2 textbooks and presented numerous papers, lectures, and workshops nationally and internationally.

• Impact of Reduced Tobacco Smoking on Lung Cancer Mortality in the United States During 1975–2000
• A simulation model of clinical and economic outcomes of cardiac CT triage of patients with acute chest pain in the emergency department.
• Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers: A comparative effectiveness analysis.
• Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw.
• Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003.

• Risk Communication Methods
• The Effect of Self-referral on Cost and Utilization of Diagnostic Imaging Tests
• Program in Cancer Outcomes Research Training
• CT Colonoscopy Screening for CRC: Comparative Effectiveness vs. Traditional Models
• ROMICAT II Trial: a randomized, multi-center cardiac CT trial